Author | Eduardo Diaz-rubio, MD, PhD

Articles

UFT/Methotrexate/Leucovorin for Breast Cancer Patients in Progression After HDCT/PBPC Support

September 02, 1997

Twenty-four patients with metastatic breast cancer that had progressed after high-dose chemotherapy with peripheral blood progenitor cell (PBPC) support were given intramuscular methotrexate in combination with oral

Neoadjuvant Therapy With Cisplatin/Fluorouracil vs Cisplatin/UFT in Locally Advanced Squamous Cell Head and Neck Cancer

September 02, 1997

This study compared the activity and toxicity of fluorouracil (5-FU)/cisplatin with the combination tegafur and uracil (UFT)/cisplatin in the neoadjuvant treatment of locally advanced-stage III or IV (M0)-head and neck

UFT Plus Oral Folinic Acid as Therapy for Metastatic Colorectal Cancer in Older Patients

September 02, 1997

The oral fluoropyrimidines have proved to be active in colorectal cancer in Japan and, recently, in the United States and Europe. Continuous oral administration simulates protracted fluorouracil (5-FU) continuous